鳥インフルエンザA(H7N9)は、インフルエンザウイルスの亜型の一つです。この感染症は、ヒトと鳥類の両方で見られます。感染した家禽類や汚染された環境に人がさらされることで感染が起こります。症状は、発熱、痰の出る咳、頭痛、筋肉痛、全身倦怠感などです。治療には、抗ウイルス薬が用いられます。
目次
Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Influenza A Virus, H7N9 Subtype Infections - Overview
Influenza A Virus, H7N9 Subtype Infections - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Influenza A Virus, H7N9 Subtype Infections - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Influenza A Virus, H7N9 Subtype Infections - Companies Involved in Therapeutics Development
AIM ImmunoTech Inc
AusBio Ltd
Beijing Tiantan Biological Products Co Ltd
Celdara Medical LLC
Cocrystal Pharma Inc
Codagenix Inc
CSL Ltd
EpiVax Inc
Greffex Inc
GSK plc
Hualan Biological Bacterin Co Ltd
Inovio Pharmaceuticals Inc
Medicago Inc
NanoViricides Inc
New Amsterdam Sciences Inc
Ology Bioservices Inc
Pneumagen Ltd
TaiGen Biotechnology Co Ltd
Influenza A Virus, H7N9 Subtype Infections - Drug Profiles
CC-42344 - Drug Profile
Product Description
Mechanism Of Action
CDX-H7N9 - Drug Profile
Product Description
Mechanism Of Action
CMBT-1 - Drug Profile
Product Description
Mechanism Of Action
GSK-3206641A - Drug Profile
Product Description
Mechanism Of Action
influenza [strain A/H7N9] (monovalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
influenza [strain A/H7N9] (monovalent) vaccine 1 - Drug Profile
Product Description
Mechanism Of Action
influenza [strain A/H7N9] (monovalent) vaccine 2 - Drug Profile
Product Description
Mechanism Of Action
influenza [strain A/H7N9] (split virion) vaccine - Drug Profile
Product Description
Mechanism Of Action
influenza [strain A/H7N9] vaccine - Drug Profile
Product Description
Mechanism Of Action
influenza [strain A/H7N9] vaccine - Drug Profile
Product Description
Mechanism Of Action
influenza [strain A/H7N9] vaccine - Drug Profile
Product Description
Mechanism Of Action
influenza [strain A/H7N9] vaccine - Drug Profile
Product Description
Mechanism Of Action
influenza [strain A/H7N9] vaccine - Drug Profile
Product Description
Mechanism Of Action
influenza [strain A/H7N9] vaccine - Drug Profile
Product Description
Mechanism Of Action
influenza [strains A/H7N9] (split virion) vaccine - Drug Profile
Product Description
Mechanism Of Action
interferon alfa-n3 - Drug Profile
Product Description
Mechanism Of Action
MD-2009 - Drug Profile
Product Description
Mechanism Of Action
MDG-7529 - Drug Profile
Product Description
Mechanism Of Action
NAS-911 - Drug Profile
Product Description
Mechanism Of Action
Neumifil - Drug Profile
Product Description
Mechanism Of Action
NVINF-1 - Drug Profile
Product Description
Mechanism Of Action
NVINF-2 - Drug Profile
Product Description
Mechanism Of Action
Recombinant Protein to Target Sialic Acid Receptor for Influenza A Infections - Drug Profile
Product Description
Mechanism Of Action
Small Molecule for Influenza Virus Infections - Drug Profile
Product Description
Mechanism Of Action
TG-1000 - Drug Profile
Product Description
Mechanism Of Action
Influenza A Virus, H7N9 Subtype Infections - Dormant Projects
Influenza A Virus, H7N9 Subtype Infections - Discontinued Products
Influenza A Virus, H7N9 Subtype Infections - Product Development Milestones
Featured News & Press Releases
Jan 10, 2019: Development and Industrialization Construction Project of Quadrivalent Influenza Vaccine of Hualan Biological Bacterin
May 23, 2018: Application of Quadrivalent Influenza Vaccine (QIV)
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Influenza A Virus, H7N9 Subtype Infections, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Influenza A Virus, H7N9 Subtype Infections - Pipeline by AIM ImmunoTech Inc, 2022
Influenza A Virus, H7N9 Subtype Infections - Pipeline by AusBio Ltd, 2022
Influenza A Virus, H7N9 Subtype Infections - Pipeline by Beijing Tiantan Biological Products Co Ltd, 2022
Influenza A Virus, H7N9 Subtype Infections - Pipeline by Celdara Medical LLC, 2022
Influenza A Virus, H7N9 Subtype Infections - Pipeline by Cocrystal Pharma Inc, 2022
Influenza A Virus, H7N9 Subtype Infections - Pipeline by Codagenix Inc, 2022
Influenza A Virus, H7N9 Subtype Infections - Pipeline by CSL Ltd, 2022
Influenza A Virus, H7N9 Subtype Infections - Pipeline by EpiVax Inc, 2022
Influenza A Virus, H7N9 Subtype Infections - Pipeline by Greffex Inc, 2022
Influenza A Virus, H7N9 Subtype Infections - Pipeline by GSK plc, 2022
Influenza A Virus, H7N9 Subtype Infections - Pipeline by Hualan Biological Bacterin Co Ltd, 2022
Influenza A Virus, H7N9 Subtype Infections - Pipeline by Inovio Pharmaceuticals Inc, 2022
Influenza A Virus, H7N9 Subtype Infections - Pipeline by Medicago Inc, 2022
Influenza A Virus, H7N9 Subtype Infections - Pipeline by NanoViricides Inc, 2022
Influenza A Virus, H7N9 Subtype Infections - Pipeline by New Amsterdam Sciences Inc, 2022
Influenza A Virus, H7N9 Subtype Infections - Pipeline by Ology Bioservices Inc, 2022
Influenza A Virus, H7N9 Subtype Infections - Pipeline by Pneumagen Ltd, 2022
Influenza A Virus, H7N9 Subtype Infections - Pipeline by TaiGen Biotechnology Co Ltd, 2022
Influenza A Virus, H7N9 Subtype Infections - Dormant Projects, 2022
Influenza A Virus, H7N9 Subtype Infections - Dormant Projects, 2022 (Contd..1)
Influenza A Virus, H7N9 Subtype Infections - Discontinued Products, 2022
List of Figures
Number of Products under Development for Influenza A Virus, H7N9 Subtype Infections, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022